Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer

  1. Grunt, T.W.
  2. Slany, A.
  3. Semkova, M.
  4. Colomer, R.
  5. López-Rodríguez, M.L.
  6. Wuczkowski, M.
  7. Wagner, R.
  8. Gerner, C.
  9. Stübiger, G.
Journal:
Scientific Reports

ISSN: 2045-2322

Year of publication: 2020

Volume: 10

Issue: 1

Type: Article

DOI: 10.1038/S41598-020-71491-Z GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus